C2N Diagnostics

C2N Diagnostics is a specialty diagnostics company focused on developing and providing advanced diagnostic solutions in brain health. They utilize high-resolution mass spectrometry to create blood tests, like the PrecivityAD tests, for the detection of Alzheimer's disease biomarkers, aiming to improve diagnosis and treatment. Their goal is to offer high-performance Alzheimer’s disease testing globally.

Buy Funded Startups lists

Funding Round:

Funding Amount: $7.025M

Date: 25-Sep-2024

Investors: Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator

Markets: Healthtech, Diagnostics, Biomarkers, Alzheimer's Disease, Biotechnology Research

HQ: St. Louis, Missouri, United States

Founded: 2007

Website: https://www.c2ndiagnostics.com/

LinkedIn: https://www.linkedin.com/company/c2n-diagnostics

Twitter: https://twitter.com/C2NDiagnostics

Instagram: